MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202627031230 A) filed by Pharmaengine, Inc. on March 16, 2026, for Spirocyclic Mta-Cooperative Prmt5 Inhibitor.

Inventors include Liu, Cheng-Hao; Lin, Long-Zhi; Wang, Hong-Ren; Mou, Jianfeng; Duan, Xinli; Yu, Qingfang; Chen, Yayu; Wang, Tong; Dong, Guangping; Chen, Bin; and Zhang, Peiyu.

The application for the patent was published on August 14, 2026, under issue no. 33/2026.

Abstract: The present invention relates to compounds used as MTA-cooperative inhibitors of protein arginine N-methyl transferase 5 (PRMT5). In particular, the present invention relates to MTA-cooperative PRMT5 inhibitors, including their pharmaceutical compositions comprising the compounds and the methods of use thereof.

Disclaimer: Curated by HT Syndication.